474 related articles for article (PubMed ID: 23582353)
1. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Kurinij N; Davis MD;
Ophthalmology; 2013 Aug; 120(8):1604-11.e4. PubMed ID: 23582353
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
[TBL] [Abstract][Full Text] [Related]
4. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
5. Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 41.
Vitale S; Agrón E; Clemons TE; Keenan TDL; Domalpally A; Danis RP; Chew EY
JAMA Ophthalmol; 2020 Jun; 138(6):610-617. PubMed ID: 32271358
[TBL] [Abstract][Full Text] [Related]
6. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
Awh CC; Lane AM; Hawken S; Zanke B; Kim IK
Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1439-52. PubMed ID: 11594943
[TBL] [Abstract][Full Text] [Related]
8. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.
Clemons TE; Milton RC; Klein R; Seddon JM; Ferris FL;
Ophthalmology; 2005 Apr; 112(4):533-9. PubMed ID: 15808240
[TBL] [Abstract][Full Text] [Related]
10. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
11. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13.
Clemons TE; Kurinij N; Sperduto RD;
Arch Ophthalmol; 2004 May; 122(5):716-26. PubMed ID: 15136320
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
13. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
[TBL] [Abstract][Full Text] [Related]
14. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.
Chew EY; Sperduto RD; Milton RC; Clemons TE; Gensler GR; Bressler SB; Klein R; Klein BE; Ferris FL
Ophthalmology; 2009 Feb; 116(2):297-303. PubMed ID: 19091420
[TBL] [Abstract][Full Text] [Related]
15. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.
Cukras C; Agrón E; Klein ML; Ferris FL; Chew EY; Gensler G; Wong WT;
Ophthalmology; 2010 Mar; 117(3):489-99. PubMed ID: 20079925
[TBL] [Abstract][Full Text] [Related]
16. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
17. Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study.
Snyder K; Yazdanyar A; Mahajan A; Yiu G
JAMA Ophthalmol; 2018 Sep; 136(9):1008-1014. PubMed ID: 29978186
[TBL] [Abstract][Full Text] [Related]
18. Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.
Awh CC; Hawken S; Zanke BW
Ophthalmology; 2015 Jan; 122(1):162-9. PubMed ID: 25200399
[TBL] [Abstract][Full Text] [Related]
19. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
Chew EY; Klein ML; Clemons TE; Agrón E; Ratnapriya R; Edwards AO; Fritsche LG; Swaroop A; Abecasis GR;
Ophthalmology; 2014 Nov; 121(11):2173-80. PubMed ID: 24974817
[TBL] [Abstract][Full Text] [Related]
20. The age-related eye disease study: the results of the clinical trial.
Sackett CS; Schenning S
Insight; 2002; 27(1):5-7. PubMed ID: 11962062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
